The DOI matches its Crossref record; 193 of the 198 references it cites were found in a registry or an index.
Cancer-associated fibroblasts in tumor microenvironment–Accomplices in tumor malignancy
Abstract
There is much cellular heterogeneity in the tumor microenvironment. The tumor epithelia and stromal cells co-evolve, and this reciprocal relationship dictates almost every step of cancer development and progression. Despite this, many anticancer therapies are designed around druggable features of tumor epithelia, ignoring the supportive role of stromal cells. Cancer-associated fibroblasts (CAFs) are the dominant cell type within the reactive stroma of many tumor types. Numerous previous studies have highlighted a pro-tumorigenic role for CAFs via secretion of various growth factors, cytokines, chemokines, and the degradation of extracellular matrix. Recent works showed that CAFs secrete H 2 O 2 to effect stromal-mediated field cancerization, transform primary epithelial cells, and aggravate cancer cell aggressiveness, in addition to inflammatory and mitogenic factors. Molecular characterization of CAFs also underscores the importance of Notch and specific nuclear receptor signaling in the activation of CAFs. This review consolidates recent findings of CAFs and highlights areas for future investigations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Secondly, metabolic disorders including cardiometabolic syndrome (CMS), diabetes, cardiovascular disease (CVD), and cancer are common comorbidities of SO (54, 55).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [55]
Citations
Cites
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Slaughter, D. P., Southwick, H. W., & Smejkal, W. (1953) · Cancer · doi:10.1002/1097-0142(195309)6:5 · Cited by 3,558
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,960
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Pankov, R. G., & Yamada, K. M. (2002) · Journal of Cell Science · doi:10.1242/jcs.00059 · Cited by 2,055
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Ömeroğlu, G., Meterissian, S. H., Ömeroğlu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,707
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Braakhuis, B. J. M., Tabor, M. P., Kummer, J. A., Leemans, C. R., & Brakenhoff, R. H. (2003) · PubMed · Cited by 1,208
Immune cell promotion of metastasis
Kitamura, T., Qian, B.-Z., & Pollard, J. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3789 · Cited by 1,158
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
Kidd, P. M. (2003) · PubMed · Cited by 1,102
Progress in matrix metalloproteinase research
MURPHY, G., & Nagase, H. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.002 · Cited by 778
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
Carcinoma-associated fibroblasts: orchestrating the composition of malignancyPreprint
Gascard, P. D., & Tlsty, T. D. (2016) · Genes & Development · doi:10.1101/gad.279737.116 · Cited by 770
Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
Richards, K. E., Zeleniak, A. E., Fishel, M. L., Wu, J., Littlepage, L. E., & Hill, R. (2016) · Oncogene · doi:10.1038/onc.2016.353 · Cited by 753
Identification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 730
Tan, W., Zhang, W., Strasner, A., Grivennikov, S. I., Cheng, J. Q., Hoffman, R. M., & Karin, M. (2011) · Nature · doi:10.1038/nature09707 · Cited by 658
Co-evolution of tumor cells and their microenvironment
Polyák, K., Haviv, I., & Campbell, I. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.10.012 · Cited by 640
Park, J. E., Lenter, M., Zimmermann, R., Garin‐Chesa, P., Old, L. J., & Rettig, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36505 · Cited by 591
Erdoğan, B., & Webb, D. J. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160387 · Cited by 583
Clinical significance of macrophage heterogeneity in human malignant tumors
Komohara, Y., Jinushi, M., & Takeya, M. (2013) · Cancer Science · doi:10.1111/cas.12314 · Cited by 565
Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin
Erdogan, B., Ao, M., White, L. M., Means, A. L., Brewer, B. M., Yang, L., Washington, M. K., Shi, C., Franco, O. E., Weaver, A. M., et al. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201704053 · Cited by 552
Comito, G., Giannoni, E., Segura, C. P., Barcellos‐de‐Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2013) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 546
Metastasis suppressors alter the signal transduction of cancer cells
Steeg, P. S. (2003) · Nature reviews. Cancer · doi:10.1038/nrc967 · Cited by 509
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells
Lo, A., Wang, L.-C. S., Scholler, J., Monslow, J., Avery, D., Newick, K., O'Brien, S., Evans, R. A., Bajor, D. J., Clendenin, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3041 · Cited by 498
Cancer and the tumor microenvironment: a review of an essential relationship
Mbeunkui, F., & Johann, D. J. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0881-9 · Cited by 485
Tran, E., Chinnasamy, D., Yu, Z., Morgan, R. A., Lee, C. R., Restifo, N. P., & Rosenberg, S. A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130110 · Cited by 481
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Shi, Y., Du, L., Lin, L., & Wang, Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.193 · Cited by 463
Liao, D., Luo, Y., Markowitz, D., Xiang, R., & Reisfeld, R. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007965 · Cited by 437
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Santos, A., Jung, J. J., Aziz, N., Kissil, J. L., & Puré, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38988 · Cited by 436
Role of organ selectivity in the determination of metastatic patterns of B16 melanoma.
Hart, I. R., & Fidler, I. J. (1980) · PubMed · Cited by 428
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
Wang, W., Kryczek, I., Dostál, L., Lin, H., Tan, L., Zhao, L., Lu, F., Wei, S., Maj, T., Peng, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.009 · Cited by 422
Blokzijl, A., Dahlqvist, C., Reissmann, E., Falk, A., Moliner, A., Lendahl, U., & Ibáñez, C. F. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305112 · Cited by 396
Hofheinz, R., Al‐Batran, S., Hartmann, F., Hartung, G., Jäger, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H., et al. (2003) · Oncology Research and Treatment · doi:10.1159/000069863 · Cited by 377
Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
Henry, L. R., Lee, H., Lee, J. S., Klein–Szanto, A. J., Watts, P., Ross, E. A., Chen, W., & Cheng, J. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1746 · Cited by 372
Navab, R., Strumpf, D., Bandarchi, B., Zhu, C., Pintilie, M., Ramnarine, V. R., Ibrahimov, E., Radulovich, N., Leung, L., Barczyk, M. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014506108 · Cited by 370
Soto, A. M., & Sonnenschein, C. (2011) · BioEssays · doi:10.1002/bies.201100025 · Cited by 353
Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer
辻野, 督., Seshimo, I., Yamamoto, H., Ngan, C. Y., Ezumi, K., Takemasa, I., Ikeda, M., Sekimoto, M., Matsuura∥, N., & Monden, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2191 · Cited by 353
Hu, Y., Yan, C., Mu, L., Huang, K., Li, X., Tao, D., Wu, Y., & Qin, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125625 · Cited by 352
Oxidative stress promotes myofibroblast differentiation and tumour spreading
Toullec, A., Gerald, D., Despouy, G., Bourachot, B., Cardon, M., Lefort, S., Richardson, M., Rigaill, G., Parrini, M., Lucchesi, C., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000073 · Cited by 339
Stromal features are predictive of disease mortality in oral cancer patients
Marsh, D. J., Suchak, K., Moutasim, K. A., Vallath, S., Hopper, C., Jerjes, W., Upile, T., Kalavrezos, N., Violette, S. M., Weinreb, P. H., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2830 · Cited by 339
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression
Shimoda, M., Mellody, K. T., & Orimo, A. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.10.002 · Cited by 337
Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues
Sappino, A. P., Skalli, O., Jackson, B. W., Schürch, W., & Gabbiani, G. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410512 · Cited by 325
Brennen, W. N., Isaacs, J. T., & Denmeade, S. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0340 · Cited by 302
Fibroblast activation in cancer: when seed fertilizes soil
Kužet, S.-E., & Gaggioli, C. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2467-x · Cited by 301
Herrera, M., Herrera, A., Domínguez, G., Silva, J., García‐Barberán, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., et al. (2013) · Cancer Science · doi:10.1111/cas.12096 · Cited by 298
Zhu, P., Tan, M., Huang, R.-L., Tan, C. K., Chong, H. C., Pal, M., Lam, C. R. I., Boukamp, P., Pan, J. Y., Tan, S. H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.018 · Cited by 288
Self-citationQiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S. B., Shipitsin, M. V., Trivett, M. K., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 287
Narra, K., Mullins, S., Lee, H.-O., Strzemkowski-Brun, B., Magalong, K., Christiansen, V. J., McKee, P. A., Egleston, B. L., Cohen, S. J., Weiner, L. M., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.11.4874 · Cited by 285
Cheng, N., Bhowmick, N. A., Chytil, A., Gorksa, A. E., Brown, K. A., Muraoka, R. S., Arteaga, C. L., Neilson, E. G., Hayward, S. W., & Moses, H. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208685 · Cited by 272
Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapyPreprint
Logue, J. S., & Morrison, D. K. (2012) · Genes & Development · doi:10.1101/gad.186965.112 · Cited by 259
Large oncosomes mediate intercellular transfer of functional microRNA
Morello, M., Minciacchi, V. R., de Candia, P., Yang, J., Posadas, E. M., Kim, H. L., Griffiths, D., Bhowmick, N. A., Chung, L. W. K., Gandellini, P., et al. (2013) · Cell Cycle · doi:10.4161/cc.26539 · Cited by 251
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
Ireland, L., Santos, A., Ahmed, M. S., Rainer, C., Nielsen, S. R., Quaranta, V., Weyer-Czernilofsky, U., Engle, D. D., Pérez-Mancera, P. A., Coupland, S. E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1201 · Cited by 248
Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
Jiang, H., Hegde, S., & DeNardo, D. G. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2003-1 · Cited by 246
Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma
Cohen, S. J., Alpaugh, R. K., Palazzo, I., Meropol, N. J., Rogatko, A., Xu, Z., Hoffman, J. P., Weiner, L. M., & Cheng, J. D. (2008) · Pancreas · doi:10.1097/mpa.0b013e31816618ce · Cited by 244
McDonald, S. A. C., Greaves, L. C., Gutierrez–Gonzalez, L., Rodriguez–Justo, M., Deheragoda, M., Leedham, S. J., Taylor, R. W., Lee, C. Y., Preston, S. L., Lovell, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.035 · Cited by 242
Weber, C., Kothari, A. N., Wai, P. Y., Li, N. Y., Driver, J., Zapf, M. A. C., Franzen, C. A., Gupta, G. N., Osipo, C., Zlobin, A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.410 · Cited by 235
Nakagawa, H., Liyanarachchi, S., Davuluri, R. V., Auer, H., Martin, E. W., de la Chapelle, A., & Frankel, W. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208013 · Cited by 232
Yamashita, M., Ogawa, T., Zhang, X., Hanamura, N., Kashikura, Y., Takamura, M., Yoneda, M., & Shiraishi, T. (2010) · Breast Cancer · doi:10.1007/s12282-010-0234-5 · Cited by 223
Duluc, C., Moatassim-Billah, S., Chalabi‐Dchar, M., Perraud, A., Samain, R., Breibach, F., Gayral, M., Cordelier, P., Delisle, M., Bousquet, M., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404346 · Cited by 218
Kawase, A., Ishii, G., Nagai, K., Itô, T., Nagano, T., Murata, Y., Hishida, T., Nishimura, M., Yoshida, J., Suzuki, K. Z., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23611 · Cited by 212
Multifocal Epithelial Tumors and Field Cancerization from Loss of Mesenchymal CSL Signaling
Hu, B., Castillo, E., Harewood, L., Ostano, P., Reymond, A., Dummer, R., Raffoul, W., Hoetzenecker, W., Hofbauer, G. F. L., & Dotto, G. P. (2012) · Cell · doi:10.1016/j.cell.2012.03.048 · Cited by 211
Hanley, C. J., Noble, F., Ward, M. J., Bullock, M. D., Drifka, C. R., Mellone, M., Manousopoulou, A., Johnston, H. E., Hayden, A. L., Thirdborough, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6740 · Cited by 209
Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer
Tommelein, J., Verset, L., Boterberg, T., Demetter, P., Bracke, M., & Wever, O. D. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00063 · Cited by 207
Fibronectin-guided migration of carcinoma collectives
Gopal, S., Veracini, L., Grall, D., Butori, C., Schaub, S., Audebert, S., Camoin, L., Baudelet, É., Radwańska, A., Divonne, S. B.-D. L. F., et al. (2017) · Nature Communications · doi:10.1038/ncomms14105 · Cited by 204
CAFs and TAMs: maestros of the tumour microenvironment
Komohara, Y., & Takeya, M. (2016) · The Journal of Pathology · doi:10.1002/path.4824 · Cited by 199
Josson, S., Gururajan, M., Sung, S., Hu, P., Shao, C., Zhau, H. E., Liu, C., Lichterman, J. N., Duan, P., Li, Q., et al. (2014) · Oncogene · doi:10.1038/onc.2014.212 · Cited by 197
Kim, R., Emi, M., & Tanabe, K. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02430.x · Cited by 195
Fujii, N., Shomori, K., Shiomi, T., Nakabayashi, M., Takeda, C., Ryoke, K., & Ito, H. (2012) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2012.01127.x · Cited by 192
Hashimoto, O., Yoshida, M., Koma, Y., Yanai, T., Hasegawa, D., Kosaka, Y., Nishimura, N., & Yokozaki, H. (2016) · The Journal of Pathology · doi:10.1002/path.4769 · Cited by 190
Brennen, W. N., Rosen, D. M., Wang, H., Isaacs, J. T., & Denmeade, S. R. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs336 · Cited by 189
Izumi, D., Ishimoto, T., Miyake, K., Sugihara, H., Eto, K., Sawayama, H., Yasuda, T., Kiyozumi, Y., Kaida, T., Kurashige, J., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29864 · Cited by 188
Underwood, T., Hayden, A. L., Derouet, M. F., Garcia, E., Noble, F., White, M. J., Thirdborough, S., Mead, A., Clemons, N. J., Mellone, M., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4467 · Cited by 187
Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis
Franco, O. E., Jiang, M., Strand, D. W., Peacock, J. W., Fernandez, S., Jackson, R. S., Revelo, M. P., Bhowmick, N. A., & Hayward, S. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3142 · Cited by 185
Stromal Modulators of TGF-β in Cancer
Costanza, B., Umelo, I. A., Bellier, J., Castronovo, V., & Turtoï, A. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6010007 · Cited by 183
The role of endothelial-mesenchymal transition in development and pathological process
Lin, F., Wang, N., & Zhang, T. (2012) · IUBMB Life · doi:10.1002/iub.1059 · Cited by 177
Herrera, M., Islam, A. B. M. M. K., Herrera, A., Martín, P., García‐Barberán, V., Silva, J., Garcia, J. M., Salas, C., Casal, J. I., de Herreros, A. G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0694 · Cited by 177
Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast
Bauer, M. W., Su, G.-Y., Casper, C., He, R., Rehrauer, W. M., & Friedl, A. (2010) · Oncogene · doi:10.1038/onc.2009.463 · Cited by 176
Wikberg, M. L., Edin, S., Lundberg, I. V., Guelpen, B. R. V., Dahlin, A. M., Rutegård, M., Stenling, R., Öberg, Å., & Palmqvist, R. (2013) · Tumor Biology · doi:10.1007/s13277-012-0638-2 · Cited by 172
Role of myeloid cells in tumor angiogenesis and growth
Shojaei, F., Zhong, C., Wu, X., Yu, L., & Ferrara, N. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.06.003 · Cited by 169
Shindo, K., Aishima, S., Ohuchida, K., Fujiwara, K., Fujino, M., Mizuuchi, Y., Hattori, M., Mizumoto, K., Tanaka, M., & Oda, Y. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-168 · Cited by 165
Freier, K., Schwäenen, C., Sticht, C., Flechtenmacher, C., Mühling, J., Hofele, C., Radlwimmer, B., Lichter, P., & Joos, S. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.01.005 · Cited by 165
Lee, J., Faßnacht, M., Nair, S. K., Boczkowski, D., & Gilboa, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2805 · Cited by 159
Sato, N., Maehara, N., & Goggins, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0677 · Cited by 158
Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
Ngan, C. Y., Yamamoto, H., Seshimo, I., Tsujino, T., Man-i, M., Ikeda, J.-I., Konishi, K., Takemasa, I., Ikeda, M., Sekimoto, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603651 · Cited by 150
Evidence for field cancerization of the prostate
Nonn, L., Ananthanarayanan, V., & Gann, P. H. (2009) · The Prostate · doi:10.1002/pros.20983 · Cited by 150
Fullár, A., Dudás, J., Oláh, L., Hollósi, P., Papp, Z., Sobel, G., Karászi, K., Paku, S., Baghy, K., & Kovalszky, I. (2015) · BMC Cancer · doi:10.1186/s12885-015-1272-3 · Cited by 144
Niessner, H., Forschner, A., Klumpp, B. D., Honegger, J. B., Witte, M. B., Bornemann, A., Dummer, R., ADAM, A., Bauer, J. M., Tabatabai, G., et al. (2012) · Cancer Medicine · doi:10.1002/cam4.50 · Cited by 143
Gandellini, P., Andriani, F., Merlino, G., D’Aiuto, F., Roz, L., & Callari, M. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.008 · Cited by 140
Sinn, M., Denkert, C., Striefler, J. K., Pelzer, U., Stieler, J., Bahra, M., Lohneis, P., Dörken, B., Oettle, H., Riess, H. B., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.495 · Cited by 139
Bohling, S. D., & Allison, K. H. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.160 · Cited by 139
Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts
Arcucci, A., Ruocco, M. R., Granato, G., Sacco, A. M., & Montagnani, S. (2016) · BioMed Research International · doi:10.1155/2016/4502846 · Cited by 139
TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
Novitskiy, S. V., Pickup, M. W., Gorska, A. E., Owens, P., Chytil, A., Aakre, M. E., Wu, H., Shyr, Y., & Moses, H. L. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0100 · Cited by 138
Bello, I. O., Vered, M., Dayan, D., Dobriyan, A., Yahalom, R., Alanen, K. A., Nieminen, P. A., Kantola, S., Läärä, E., & Salo, T. A. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.10.013 · Cited by 137
Mammary field cancerization: molecular evidence and clinical importance
Heaphy, C. M., Griffith, J. K., & Bisoffi, M. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0504-0 · Cited by 136
Tao, L., Huang, G., Wang, R., Pan, Y., He, Z., Chu, X., Song, H., & Chen, L. (2016) · Scientific Reports · doi:10.1038/srep38408 · Cited by 135
Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis
Kellermann, M. G., Sobral, L. M., da Silva, S. D., Zecchin, K. G., Graner, E., Lopes, M. A., Nishimoto, I. N., Kowalski, L. P., & Coletta, R. D. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02873.x · Cited by 135
Neri, S., Ishii, G., Hashimoto, H., Kuwata, T., Nagai, K., Date, H., & Ochiai, A. (2015) · International Journal of Cancer · doi:10.1002/ijc.29464 · Cited by 134
Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress
Chan, J. S. K., Tan, M. J., Sng, M. K., Teo, Z., Phua, T., Choo, C. C., LI, L., Zhu, P., & Tan, N. S. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.492 · Cited by 130
Self-citationZiani, L., Safta, T. B., Gourbeix, J., Cavalcanti, A., Robert, C., Favre, G., Chouaı̈b, S., & Thiery, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15540 · Cited by 129
The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma
Ha, S. Y., Yeo, S.-Y., Xuan, Y.-H., & Kim, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099955 · Cited by 127
Hasegawa, T., Yashiro, M., Nishii, T., Matsuoka, J., Fuyuhiro, Y., Morisaki, T., Fukuoka, T., Shimizu, K., Shimizu, T., Miwa, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28520 · Cited by 126
Yoshida, T., Ishii, G., Goto, K., Neri, S., Hashimoto, H., Yoh, K., Niho, S., Umemura, S., Matsumoto, S., Ohmatsu, H., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0846 · Cited by 125
Kawashiri, S., Tanaka, A., Noguchi, N., Hase, T., Nakaya, H., Ohara, T., Kato, K., & Yamamoto, E. (2009) · Head & Neck · doi:10.1002/hed.21097 · Cited by 125
Prognostic Impact of Cancer-Associated Stromal Cells in Patients With Stage I Lung Adenocarcinoma
Ito, M., Ishii, G., Nagai, K., Maeda, R., Nakano, Y., & Ochiai, A. (2012) · CHEST Journal · doi:10.1378/chest.11-2458 · Cited by 123
Turning it up a Notch: cross-talk between TGFβ and Notch signaling: What the papers say
Klüppel, M., & Wrana, J. L. (2005) · BioEssays · doi:10.1002/bies.20187 · Cited by 121
Precancerous lesions in the stomach: From biology to clinical patient management
Rugge, M., Capelle, L. G., Cappellesso, R., Nitti, D., & Kuipers, E. J. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.12.007 · Cited by 116
p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner
Addadi, Y., Moskovits, N. B.-C., Granot, D., Lozano, G., Carmi, Y., Apte, R. N., Neeman, M., & Oren, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1146 · Cited by 109
A Cancer Theory Kerfuffle Can Lead to New Lines of Research
Baker, S. G. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju405 · Cited by 107
Li, M., Li, M., Yin, T., Shi, H., WEN, Y., Zhang, B., Chen, M., Xu, G., Ren, K., & Wei, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4868 · Cited by 106
SCHOPPMANN, S. F., Berghoff, A. S., Dinhof, C., Jakesz, R., Gnant, M., Dubsky, P. C., Jesch, B., Heinzl, H., & Birner, P. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1984-x · Cited by 103
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Tchou, J. C., Kossenkov, A. V., Chang, L., Satija, C., Herlyn, M., Showe, L. C., & Puré, E. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-39 · Cited by 101
Vered, M., Dobriyan, A., Dayan, D., Yahalom, R., Talmi, Y. P., Bedrin, L., Barshack, I., & Taicher, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01357.x · Cited by 101
Puła, B., Jethon, A., Piotrowska, A., Gomułkiewicz, A., Owczarek, T. B., Calik, J., Wojnar, A., Witkiewicz, W., Ryś, J., Ugorski, M., et al. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04060.x · Cited by 99
Somatic Mutation Theory - Why it's Wrong for Most Cancers
Brücher, B. L. D. M., & Jamall, I. S. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443106 · Cited by 99
Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer
Protti, M. P., & Monte, L. B. D. (2012) · OncoImmunology · doi:10.4161/onci.1.1.17939 · Cited by 97
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
Ohara, M., Yamaguchi, Y., Matsuura, K., Murakami, S., Arihiro, K., & Okada, M. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0570-x · Cited by 96
Hendrayani, S., Al‐Khalaf, H. H., & Aboussekhra, A. (2013) · Neoplasia · doi:10.1593/neo.13478 · Cited by 95
Surowiak, P., Murawa, D., Materna, V., Maciejczyk, A., Pudełko, M., Cieśla, S., Bręborowicz, J., Murawa, P., Zabel, M., Dietel, M., et al. (2007) · PubMed · Cited by 95
In defense of the somatic mutation theory of cancer
Vaux, D. L. (2011) · BioEssays · doi:10.1002/bies.201100022 · Cited by 95
Kitano, H., Kageyama, S., Hewitt, S. M., Hayashi, R., Doki, Y., Ozaki, Y., Fujino, S., Takikita, M., Kubo, H., & Fukuoka, J. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0114-oa.1 · Cited by 93
Li, X., Xu, Q., Wu, Y., Li, J., Tang, D., Han, L., & Fan, Q. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu046 · Cited by 91
Shen, H., Yu, X., Yang, F., Zhang, Z., Shen, J., Sun, J., Choksi, S., Jitkaew, S., & Shu, Y. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006244 · Cited by 91
SCHOPPMANN, S. F., Jesch, B., Riegler, M. F., Maroske, F., Schwameis, K., Jomrich, G., & Birner, P. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9549-2 · Cited by 90
Ding, L., Zhang, Z., Shang, D., Cheng, J., Yuan, H., Wu, Y., Song, X., & Jiang, H. (2013) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12143 · Cited by 89
Liao, Y., Ni, Y., Ren, H., Liu, W., & Du, J. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1471-8 · Cited by 88
Wald, O., Izhar, U., Amir, G., Kirshberg, S., Shlomai, Z., Zamir, G. A., Peled, A., & Shapira, O. M. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.11.056 · Cited by 85
Transcriptomic Architecture of the Adjacent Airway Field Cancerization in Non–Small Cell Lung Cancer
Kadara, H. N., Fujimoto, J., Yoo, S., Maki, Y., Gower, A. C., Kabbout, M., Garcia, M. M., Chow, C.-W. B., Chu, Z., Mendoza, G., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju004 · Cited by 85
Breast Carcinoma–Associated Fibroblasts Rarely Contain p53 Mutations or Chromosomal Aberrations
Hosein, A. N., Wu, M., Arcand, S. L., Lavallée, S., Hébert, J., Tonin, P. N., & Basik, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0673 · Cited by 84
Horie, M., Saito, A., Mikami, Y., Ohshima, M., Morishita, Y., Nakajima, J., Kohyama, T., & Nagase, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.104 · Cited by 83
Retinoic acid receptors interfere with the TGF-β/Smad signaling pathway in a ligand-specific manner
Pendaries, V., Verrecchia, F., Michel, S., & Mauviel, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206913 · Cited by 82
Yamanashi, T., Nakanishi, Y., Fujii, G., Akishima‐Fukasawa, Y., Moriya, Y., Kanai, Y., Watanabe, M., & Hirohashi, S. (2009) · Oncology · doi:10.1159/000226112 · Cited by 82
TAP1 down-regulation in primary melanoma lesions: An independent marker of poor prognosis
Kamarashev, J. A., Ferrone, S., Seifert, B., B�ni, R., Nestle, F. O., Burg, G., & Dummer, R. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010120)95:1 · Cited by 79
Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer
Yu, Y. H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i33.9717 · Cited by 78
Cutaneous field cancerization: clinical, histopathological and therapeutic aspects
Torezan, L. A. R., & Neto, C. F. (2013) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20132300 · Cited by 77
Schor, S. L., Ellis, I., Jones, S. J., Baillie, R., Seneviratne, K., Clausen, J., Motegi, K., Vojtesek, B., Kaňková, K., Furrie, E., et al. (2003) · PubMed · Cited by 76
Mazur, A., Holthoff, E. R., Vadali, S., Kelly, T. J., & Post, S. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150287 · Cited by 75
One microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 75
Essential role of Smad3 in the inhibition of inflammation‐induced PPARβ/δ expression
Tan, N. S., Michalik, L., Di‐Poï, N., Ng, C. Y., Mermod, N., Roberts, A. B., Desvergne, B., & Wahli, W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600437 · Cited by 74
Self-citationStadler, M., Walter, S., Walzl, A., Kramer, N., Unger, C., Scherzer, M., Unterleuthner, D., Hengstschläger, M., Krupitza, G., & Dolznig, H. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.007 · Cited by 73
Evidence for field effect cancerization in colorectal cancer
Hawthorn, L., Lan, L., & Mojica, W. D. (2013) · Genomics · doi:10.1016/j.ygeno.2013.11.003 · Cited by 73
Schwartze, J. T., Becker, S., Sakkas, E., Wujak, L. A., Niess, G., Usemann, J., Reichenberger, F., Herold, S., Vadász, I., Mayer, K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541052 · Cited by 72
Doldi, V., Callari, M., Giannoni, E., D’Aiuto, F., Maffezzini, M., Valdagni, R., Chiarugi, P., Gandellini, P., & Zaffaroni, N. (2015) · Oncotarget · doi:10.18632/oncotarget.5056 · Cited by 72
Mechanobiology of tumor invasion: Engineering meets oncology
Carey, S. P., D’Alfonso, T. M., Shin, S. J., & Reinhart‐King, C. A. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.11.005 · Cited by 72
Müerköster, S. S., Werbing, V., Koch, D., Sipos, B., Ammerpohl, O., Kalthoff, H., Tsao, M., Fölsch, U. R., & Schäfer, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23703 · Cited by 71
Chan, J. S. K., Sng, M. K., Teo, Z. Q., Chong, H. C., Twang, J. S., & Tan, N. S. (2017) · Oncogene · doi:10.1038/onc.2017.319 · Cited by 67
Self-citationThe fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis
Xu, K., Tian, X., Oh, S. Y., Movassaghi, M., Naber, S. P., Kuperwasser, C., & Buchsbaum, R. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0674-8 · Cited by 66
Targeting the Tumor Stroma as a Novel Treatment Strategy for Breast Cancer
Tchou, J. C., & Conejo-Garcia, J. R. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00003-8 · Cited by 63
Ono, S., Ishii, G., Nagai, K., Takuwa, T., Yoshida, J., Nishimura, M., Hishida, T., Aokage, K., Fujii, S., Ikeda, N., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-0913 · Cited by 63
Wen, S., Niu, Y., Yeh, S., & Chang, C. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3060 · Cited by 63
Yasuda, K., Torigoe, T., Mariya, T., Asano, T., Kuroda, T., Matsuzaki, J., Ikeda, K., Yamauchi, M., Emori, M., Asanuma, H., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.122 · Cited by 63
Li, J., Jia, Z., Kong, J., Zhang, F., Fang, S., Li, X., Li, W., Yang, X., Luo, Y., Lin, B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150247 · Cited by 61
Liu, F., Mo, E., Yang, L., Du, J., Wang, H., Zhang, H., Kurihara, H., Xu, J., & Cai, S. (2015) · Oncotarget · doi:10.18632/oncotarget.6702 · Cited by 60
Hase, T., Kawashiri, S., Tanaka, A., Nozaki, S., Noguchi, N., Kato, K., Nakaya, H., & Nakagawa, K. (2006) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2006.00397.x · Cited by 58
An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer
Raz, Y., & Erez, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.022 · Cited by 55
Stromal contributions to the carcinogenic process
Spaw, M. C., Anant, S., & Thomas, S. M. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22583 · Cited by 54
Rivenbark, A. G., & Coleman, W. B. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.10.018 · Cited by 53
Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics
Vlieghere, E. D., Verset, L., Demetter, P., Bracke, M., & Wever, O. D. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1818-4 · Cited by 50
Kang, N., Shah, V. H., & Urrutia, R. A. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0542 · Cited by 47
Inflammatory fibroblasts in cancer
Lim, H., & Moon, A. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0787-8 · Cited by 46
Field Cancerization: Something New Under the Sun
Vanharanta, S., & Massagué, J. (2012) · Cell · doi:10.1016/j.cell.2012.05.013 · Cited by 44
Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer
Verset, L., Tommelein, J., Lopez, X. M., Decaestecker, C., Boterberg, T., Vlieghere, E. D., Salmon, I. J., Mareel, M. M. K., Bracke, M., Wever, O. D., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.05.007 · Cited by 43
Watanabe‐Takano, H., Takano, K., Hatano, M., Tokuhisa, T., & Endo, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127888 · Cited by 42
Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells
Steinbichler, T. B., Metzler, V. M., Pritz, C. O., Riechelmann, H., & Dudás, J. (2015) · Oncotarget · doi:10.18632/oncotarget.6210 · Cited by 42
SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis
Zhou, P., Xiao, N., Wang, J., Wang, Z., Zheng, S., Shan, S., Wang, J., Du, J., & Wang, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.041 · Cited by 41
Chen, Y., Zou, L., Zhang, Y., Chen, Y., Xing, P., Yang, W., Li, F., Ji, X., Liu, F., & Lu, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-1908-y · Cited by 40
Kulasekara, K. K., Lukandu, O. M., Neppelberg, E., Vintermyr, O. K., Johannessen, A. C., & Costea, D. E. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.07.004 · Cited by 39
Field Cancerization in Sporadic Colon Cancer
Park, S., Song, C. S., Yang, H., Jung, Y. S., Choi, K. Y., Koo, D., Kim, K. E., Jeong, K. U., Kim, H. O., Kim, H., et al. (2016) · Gut and Liver · doi:10.5009/gnl15334 · Cited by 39
Guzman, A., Alemany, V. S., Nguyen, Y. T.-K., Zhang, C. R., & Kaufman, L. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.014 · Cited by 38
Wang, Z., Tan, Y., Yu, W., Zheng, S. S., Zhang, S., Sun, L., & Ding, K. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.17680 · Cited by 37
Ipenburg, N. A., Koole, K., Liem, K. S., van Kempen, P. M. W., Koole, R., van Diest, P. J., van Es, R. J. J., & Willems, S. M. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0374-9 · Cited by 36
Sato, T., Ota, T., Watanabe, M., Imada, K., Nomizu, M., & Itô, A. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.04.004 · Cited by 35
Metabolic hijacking: A survival strategy cancer cells exploit?
Mitchell, M. I., & Engelbrecht, A. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.010 · Cited by 30
Fu, Z., Zuo, Y., Li, D., Xu, W., Li, D., Chen, H., & Zheng, S. S. (2013) · Acta Oncologica · doi:10.3109/0284186x.2012.760847 · Cited by 23
Negative control of CSL gene transcription by stress/DNA damage response and p53
Menietti, E., Xu, X., Ostano, P., Joseph, J., Lefort, K., & Dotto, G. P. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1186317 · Cited by 20
Jones, A. C., Trujillo, K. A., Phillips, G. K., Fleet, T. M., Murton, J. K., Severns, V., Shah, S. K., Davis, M. S., Smith, A. Y., Griffith, J. K., et al. (2011) · The Prostate · doi:10.1002/pros.22465 · Cited by 19
Koriyama, H., Ishii, G., Yoh, K., Neri, S., Morise, M., Umemura, S., Matsumoto, S., Niho, S., Ohmatsu, H., Tsuboi, M., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1891-0 · Cited by 17
Shao, H., Kong, R., Ferrari, M. L., Radtke, F., Capobianco, A. J., & Liu, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142815 · Cited by 16
Suicide Gene-Engineered Stromal Cells Reveal a Dynamic Regulation of Cancer Metastasis
Shen, K., Luk, S. O., Elman, J. S., Murray, R. M., Mukundan, S., & Parekkadan, B. (2016) · Scientific Reports · doi:10.1038/srep21239 · Cited by 14
Baker, S. G. (2011) · BioEssays · doi:10.1002/bies.201100124 · Cited by 12
Kirby, G., Bend, J. R., Smith, I. R., & Hayes, M. A. (1990) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(90)90077-m · Cited by 12
Cancer Metastasis – A Multistep Process
Hirschel-Scholz, S., & Sappino, A. P. (2009) · Dermatology · doi:10.1159/000247441 · Cited by 7
Seton-Rogers, S. E. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3324 · Cited by 5
Robles, A. I., & Harris, C. C. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw328 · Cited by 5
Gilbert, D. A. (2011) · BioEssays · doi:10.1002/bies.201100065 · Cited by 2
Cited by
Sorted by citations
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
A peek into cancer-associated fibroblasts: origins, functions and translational impact
LeBleu, V. S., & Kalluri, R. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.029447 · Cited by 557
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484
Self-citationEffect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Guo, S., & Deng, C. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25720 · Cited by 326
Qi, R., Bai, Y., Li, K., Liu, N., Xu, Y., Dal, E., Wang, Y., Lin, R., Wang, H., Liu, Z., et al. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100960 · Cited by 321
Metadata
- Authors
- Liao, Z., Tan, Z. W., Zhu, P., & Tan, N. S.
- Affiliations
- Nanyang Technological University (SG)
- Agency for Science, Technology and Research (SG)
- Corresponding author
- Tan, Zhen Wei
- Tan, Nguan Soon
- Venue
- Cellular Immunology
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 343
- Pages
- 103729
- ISSN
- 0008-8749 (ISSN-L)
- OpenAlex
- W2789705845
- Cited by
- 335
- References
- 198
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 49 · 2023: 61 · 2022: 55 · 2021: 52 · 2020: 28 · 2019: 24
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cellular Immunology (publishedVersion)
- PubMed (publishedVersion)
- DR-NTU (Nanyang Technological University) (submittedVersion)
- Funders
- Ministry of Education - Singapore (MOE2012-T1-001-036, MOE2014-T2-1-012, RG134/15)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor stroma, reactive stroma, tumor progression, extracellular matrix degradation, hydrogen peroxide, field cancerization, epithelial transformation, Notch signaling, nuclear receptor signaling, tumor inflammation, stromal-epithelial crosstalk
- MeSH terms
- Cancer-Associated Fibroblasts, Animals, Humans, Neoplasms, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review